skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Sample the best of Datamonitor Healthcare's research and analysis with Datamonitor Healthcare's Top Research Reports from 2019:

  • Gene Therapy: A Paradigm Shift in Medicine
  • Insight into NASH Pricing Strategies
  • Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D
  • Clinical Breakthroughs in Urological Cancers can be a Double-edged Sword as Payers are Forced to Act

Gene Therapy: A Paradigm Shift in Medicine

This whitepaper reviews several aspects of the gene therapy market including the history, trends in the volume of candidates over the past 20 years, the regulatory landscape in the US and EU and a thorough review of the pipeline.
DMHC_Gene_Therapy_Whitepaper_Cover

Insight into NASH Pricing Strategies

This whitepaper covers the issues creating debate over suitable and sustainable pricing strategy for non-alcoholic steatohepatitis (NASH) therapies such as current uptake challenges, lack of marketed analogs, and uncertainty over clinical relevance of surrogate endpoints and then looks at numerous manufacturing pricing strategies.
DMHC_NASH_Pricing_Strategy_Whitepaper_Cover

Clinical Breakthroughs in Urological Cancers can be a Double-edged Sword as Payers are Forced to Act

This whitepaper looks at how new product launches and indication expansions are creating tremendous changes in treatment practices for the three urological cancers and payer concerns about the potential impact of these therapies due to their high costs and often extended treatments.
DMHC_Clinical_Breakthroughs_Whitepaper_Cover

Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D

This whitepaper goes beyond a simple list of the best-selling drugs to look at what geographies are helping inflate prices, how top drugs benefits from marketing expertise of multiple companies, and which therapeutic areas are being targeted by the most lucrative drugs.
DMHC_Best_Selling_Drugs_Whitepaper_Cover

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: